Jonathan Gerber, MD from Levine Cancer Institute discusses 9 out of 10 achieved remission with Hypomethylating agent and next phase is to expand as a viable approach for elderly patients at the 2017 American Society of Hematology.
9 Out of 10 Achieved Remission with Hypomethylating Agent – Next phase is to expand as a viable approach for elderly patients
